Cempra Inc (NASDAQ:CEMP)
| 4.55 Delayed Data As of 4:00pm ET |  0.00 / 0.00%Today’s Change | 2.55 Today|||52-Week Range 26.95 | +62.50% Year-to-Date |
Latest CEMP News | Press Releases
No recent news for Cempra Inc.
Today’s Trading
| Previous close | 4.55 |
| Today’s open | 4.60 |
| Day’s range | 4.35 - 4.69 |
| Volume | 2,419,359 |
| Average volume (3 months) | 1,345,005 |
| Market cap | $238.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/23/2017
Growth & Valuation
| Earnings growth (last year) | -11.96% |
| Earnings growth (this year) | +54.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -34.03% |
| P/E ratio | NM |
| Price/Sales | 7.82 |
| Price/Book | 1.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYNEZynerba Pharmaceutic... | +0.74 | +4.10% |
| ARDXArdelyx Inc | +0.30 | +6.00% |
| FBIOFortress Biotech Inc | +0.05 | +1.04% |
| ZYMEZymeworks Inc | -0.66 | -7.01% |
Data as of 4:03pm ET, 06/23/2017
Financials
| Next reporting date | August 1, 2017 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$118.0M |
| Net profit margin | -654.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director David Zaccardelli |
Chief Financial Officer & Executive Vice President Mark W. Hahn |
Corporate headquarters Chapel Hill, North Carolina |
Forecasts
